Update in clinical science: MASLD in children and adolescents

Read full text
Authors: Sander Lefere, Bart G.P. Koot, Jake P. Mann, Philip Bufler, Ruth De Bruyne, Christian A. Hudert
Cited by: 13
References: 84

Abstract

Paediatric metabolic dysfunction-associated steatotic liver disease (MASLD) is an increasingly common liver disease, with an estimated global prevalence of up to 7.5% and growing concern regarding hepatic and extrahepatic complications even in early life. In this paper, we review recent advances in epidemiology, genetics, early-life risk factors, natural history and comorbidities, focusing on emerging data published in the last 3 years. We also outline a practical approach to the management of MASLD in children, integrating newly developed non-invasive tests. Lastly, we highlight key research questions to be studied in the coming years.

Fields of Study & Subjects

Liver Disease Diagnosis and Treatment Liver Disease and Transplantation Liver Diseases and Immunity

Publication details

Journal / source
Journal of Hepatology
Publisher
Elsevier BV
Volume
84
Issue
6
Pages
1164–1177
Publication date
21 February 2026
Language
EN